Sarah McCague

3.6k total citations · 1 hit paper
9 papers, 702 citations indexed

About

Sarah McCague is a scholar working on Molecular Biology, Ophthalmology and Genetics. According to data from OpenAlex, Sarah McCague has authored 9 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Ophthalmology and 2 papers in Genetics. Recurrent topics in Sarah McCague's work include Retinal Development and Disorders (7 papers), Retinal Diseases and Treatments (5 papers) and Virus-based gene therapy research (2 papers). Sarah McCague is often cited by papers focused on Retinal Development and Disorders (7 papers), Retinal Diseases and Treatments (5 papers) and Virus-based gene therapy research (2 papers). Sarah McCague collaborates with scholars based in United States, Italy and Belgium. Sarah McCague's co-authors include Katherine A. High, Kathleen Marshall, Jean Bennett, Jennifer Wellman, Daniel C. Chung, Francesca Simonelli, J. Fraser Wright, Albert M. Maguire, Zi‐Fan Yu and Okan U. Elci and has published in prestigious journals such as Ophthalmology, Science Translational Medicine and Investigative Ophthalmology & Visual Science.

In The Last Decade

Sarah McCague

7 papers receiving 690 citations

Hit Papers

Efficacy, Safety, and Durability of Voretigene Neparvovec... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers

Sarah McCague
Seok-Hong Min United States
Daniel M. Lipinski United States
Prateek K. Buch United Kingdom
Seok Hong Min United States
Markus Groppe United Kingdom
Amy Tillman United States
Jessica S. Rowlan United States
Seok-Hong Min United States
Sarah McCague
Citations per year, relative to Sarah McCague Sarah McCague (= 1×) peers Seok-Hong Min

Countries citing papers authored by Sarah McCague

Since Specialization
Citations

This map shows the geographic impact of Sarah McCague's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah McCague with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah McCague more than expected).

Fields of papers citing papers by Sarah McCague

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah McCague. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah McCague. The network helps show where Sarah McCague may publish in the future.

Co-authorship network of co-authors of Sarah McCague

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah McCague. A scholar is included among the top collaborators of Sarah McCague based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah McCague. Sarah McCague is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Small, Juliana C., Sarah McCague, Sabrina W. Yum, et al.. (2025). Real-world outcomes of delandistrogene moxeparvovec gene therapy: Motor outcomes and emerging safety concerns. Molecular Therapy. 34(1). 123–130.
2.
Alemán, Tomás S., Rachel M. Huckfeldt, Leona Serrano, et al.. (2019). AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: 2 year Results of an Ongoing Phase I/II Gene Therapy Trial. Investigative Ophthalmology & Visual Science. 60(9). 5173–5173. 5 indexed citations
3.
Maguire, Albert M., Stephen R. Russell, Jennifer Wellman, et al.. (2019). Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy. Ophthalmology. 126(9). 1273–1285. 276 indexed citations breakdown →
4.
Alemán, Tomás S., Leona Serrano, Grace Han, et al.. (2017). AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: Preliminary Six Month Safety Results of an Ongoing Phase I/II Gene Therapy Trial. Investigative Ophthalmology & Visual Science. 58(8). 4485–4485. 4 indexed citations
5.
Reape, Kathleen Z., Daniel C. Chung, Jennifer Wellman, et al.. (2017). Natural History of Individuals with Retinal Degeneration Due to Biallelic Mutations in the RPE65 Gene. Investigative Ophthalmology & Visual Science. 58(8). 1488–1488. 2 indexed citations
6.
Chung, Daniel C., Sarah McCague, Zi‐Fan Yu, et al.. (2017). Novel mobility test to assess functional vision in patients with inherited retinal dystrophies. Clinical and Experimental Ophthalmology. 46(3). 247–259. 105 indexed citations
7.
Chung, Daniel C., Jennifer Wellman, Emily Liu, et al.. (2016). The Natural History of Disease Progression in Patients With RPE65-Mediated Inherited Retinal Dystrophies. Investigative Ophthalmology & Visual Science. 57(12). 6588–6588.
8.
McCague, Sarah, Jennifer Wellman, Jean Bennett, et al.. (2015). Mobility testing validation study - Using a novel, standardized mobility test to evaluate functional vision in patients with inherited retinal degeneration. 56(7). 4774–4774. 1 indexed citations
9.
Bennett, Jean, Manzar Ashtari, Jennifer Wellman, et al.. (2012). AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness. Science Translational Medicine. 4(120). 120ra15–120ra15. 309 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026